Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Protein kinase Cε regulates nuclear translocation of extracellular signal-regulated kinase, which contributes to bradykinin-induced cyclooxygenase-2 expression

View through CrossRef
AbstractThe proinflammatory mediator bradykinin stimulated cyclooxygenase-2 (COX-2) expression and subsequently prostaglandin E2synthesis in dermal fibroblasts. The involvement of B2 receptors and Gαq in the role of bradykinin was suggested by using pharmacological inhibitors. The PKC activator PMA stimulated COX-2 mRNA expression. Bradykinin failed to induce COX-2 mRNA expression in the presence of PKC inhibitors, whereas the effect of bradykinin was observed in the absence of extracellular Ca2+. Bradykinin-induced COX-2 mRNA expression was inhibited in cells transfected with PKCε siRNA. These observations suggest that the novel PKCε is concerned with bradykinin-induced COX-2 expression. Bradykinin-induced PKCε phosphorylation and COX-2 mRNA expression were inhibited by an inhibitor of 3-phosphoinositide-dependent protein kinase-1 (PDK-1), and bradykinin-induced PDK-1 phosphorylation was inhibited by phospholipase D (PLD) inhibitors, suggesting that PLD/PDK-1 pathway contributes to bradykinin-induced PKCε activation. Pharmacological and knockdown studies suggest that the extracellular signal-regulated kinase 1 (ERK1) MAPK signaling is involved in bradykinin-induced COX-2 expression. Bradykinin-induced ERK phosphorylation was attenuated in the cells pretreated with PKC inhibitors or transfected with PKCε siRNA. We observed the interaction between PKCε and ERK by co-immunoprecipitation experiments. These observations suggest that PKCε activation contributes to the regulation of ERK1 activation. Bradykinin stimulated the accumulation of phosphorylated ERK in the nuclear fraction, that was inhibited in the cells treated with PKC inhibitors or transfected with PKCε siRNA. Consequently, we concluded that bradykinin activates PKCε via the PLD/PDK-1 pathway, which subsequently induces activation and translocation of ERK1 into the nucleus, and contributes to COX-2 expression for prostaglandin E2synthesis in dermal fibroblasts.
Title: Protein kinase Cε regulates nuclear translocation of extracellular signal-regulated kinase, which contributes to bradykinin-induced cyclooxygenase-2 expression
Description:
AbstractThe proinflammatory mediator bradykinin stimulated cyclooxygenase-2 (COX-2) expression and subsequently prostaglandin E2synthesis in dermal fibroblasts.
The involvement of B2 receptors and Gαq in the role of bradykinin was suggested by using pharmacological inhibitors.
The PKC activator PMA stimulated COX-2 mRNA expression.
Bradykinin failed to induce COX-2 mRNA expression in the presence of PKC inhibitors, whereas the effect of bradykinin was observed in the absence of extracellular Ca2+.
Bradykinin-induced COX-2 mRNA expression was inhibited in cells transfected with PKCε siRNA.
These observations suggest that the novel PKCε is concerned with bradykinin-induced COX-2 expression.
Bradykinin-induced PKCε phosphorylation and COX-2 mRNA expression were inhibited by an inhibitor of 3-phosphoinositide-dependent protein kinase-1 (PDK-1), and bradykinin-induced PDK-1 phosphorylation was inhibited by phospholipase D (PLD) inhibitors, suggesting that PLD/PDK-1 pathway contributes to bradykinin-induced PKCε activation.
Pharmacological and knockdown studies suggest that the extracellular signal-regulated kinase 1 (ERK1) MAPK signaling is involved in bradykinin-induced COX-2 expression.
Bradykinin-induced ERK phosphorylation was attenuated in the cells pretreated with PKC inhibitors or transfected with PKCε siRNA.
We observed the interaction between PKCε and ERK by co-immunoprecipitation experiments.
These observations suggest that PKCε activation contributes to the regulation of ERK1 activation.
Bradykinin stimulated the accumulation of phosphorylated ERK in the nuclear fraction, that was inhibited in the cells treated with PKC inhibitors or transfected with PKCε siRNA.
Consequently, we concluded that bradykinin activates PKCε via the PLD/PDK-1 pathway, which subsequently induces activation and translocation of ERK1 into the nucleus, and contributes to COX-2 expression for prostaglandin E2synthesis in dermal fibroblasts.

Related Results

Bradykinin peptides in kidney, blood, and other tissues of the rat.
Bradykinin peptides in kidney, blood, and other tissues of the rat.
The bradykinin peptide system is a tissue-based system with potent cardiovascular and renal effects. To investigate the regulation of this system, we developed a highly sensitive a...
Translocation Ecology of New Zealand Freshwater Mussels
Translocation Ecology of New Zealand Freshwater Mussels
<p><b>Freshwater mussels are a diverse and important group of animals that provide multiple ecosystem services as well as direct services to humans. They are also one ...
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
We examined the dose-related effects of angiotensin-converting enzyme inhibitors on circulating and tissue levels of angiotensin and bradykinin peptides by administering perindopri...
Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)
Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)
The pathophysiology of hereditary angioedema (HAE) in virtually all cases is the result of the uncontrolled production of the vasoactive peptide bradykinin. C1 inhibitor (C1-INH) i...
Bradykinin produces pulmonary vasodilation in fetal lambs: role of prostaglandin production
Bradykinin produces pulmonary vasodilation in fetal lambs: role of prostaglandin production
Bradykinin produces pulmonary vasodilation and also stimulates production of other pulmonary vasodilators, including prostaglandin I2 (PGI2) and endothelial-derived relaxing factor...
Bradykinin‐increased phospholipid deacylation‐reacylation in rat renal medulla is inhibited by dBc AMP
Bradykinin‐increased phospholipid deacylation‐reacylation in rat renal medulla is inhibited by dBc AMP
AbstractThe effect of bradykinin on the mobilization of arachidonic acid was analyzed separately by acylation and degradation.Acylating activity was determined by the incorporation...
Role of COX-2 in the Enhanced Vasoconstrictor Effect of Arachidonic Acid in the Diabetic Rat Kidney
Role of COX-2 in the Enhanced Vasoconstrictor Effect of Arachidonic Acid in the Diabetic Rat Kidney
In the rat isolated perfused kidney, arachidonic acid elicits cyclooxygenase-dependent vasoconstriction through activation of PGH 2 /TxA 2 ...
Coronary effects of exogenous and endogenous bradykinin in conscious dogs
Coronary effects of exogenous and endogenous bradykinin in conscious dogs
Summary—The effects of intravenous (iv) bolus administrations of bradykinin (0.1–1 μg·kg−1) on large and small coronary arteries were investigated in seven chronically instrumented...

Back to Top